Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 243 entries
Sorted by: Best Match Show Resources per page
Correction: Sleep and Breathing … and Cancer?.

Cancer prevention research (Philadelphia, Pa.)

[No authors listed]
PMID: 28062488
Cancer Prev Res (Phila). 2017 Jan;10(1):98. doi: 10.1158/1940-6207.CAPR-16-0283.

No abstract available.

Cite
Correction: Sleep and Breathing … and Cancer?. Cancer Prev Res (Phila). 2017;10(1):98doi: 10.1158/1940-6207.CAPR-16-0283.
(2017). Correction: Sleep and Breathing … and Cancer?. Cancer prevention research (Philadelphia, Pa.), 10(1), 98. https://doi.org/10.1158/1940-6207.CAPR-16-0283
"Correction: Sleep and Breathing … and Cancer?." Cancer prevention research (Philadelphia, Pa.) vol. 10,1 (2017): 98. doi: https://doi.org/10.1158/1940-6207.CAPR-16-0283
Correction: Sleep and Breathing … and Cancer?. Cancer Prev Res (Phila). 2017 Jan;10(1):98. doi: 10.1158/1940-6207.CAPR-16-0283. PMID: 28062488.
Copy Download .nbib Format: NLM
The Human Microbiome and Cancer.

Cancer prevention research (Philadelphia, Pa.)

Rajagopala SV, Vashee S, Oldfield LM, Suzuki Y, Venter JC, Telenti A, Nelson KE.
PMID: 28096237
Cancer Prev Res (Phila). 2017 Apr;10(4):226-234. doi: 10.1158/1940-6207.CAPR-16-0249. Epub 2017 Jan 17.

Recent scientific advances have significantly contributed to our understanding of the complex connection between the microbiome and cancer. Our bodies are continuously exposed to microbial cells, both resident and transient, as well as their byproducts, including toxic metabolites. Circulation...

Cite
Rajagopala SV, Vashee S, Oldfield LM, et al. The Human Microbiome and Cancer. Cancer Prev Res (Phila). 2017;10(4):226-234doi: 10.1158/1940-6207.CAPR-16-0249.
Rajagopala, S. V., Vashee, S., Oldfield, L. M., Suzuki, Y., Venter, J. C., Telenti, A., & Nelson, K. E. (2017). The Human Microbiome and Cancer. Cancer prevention research (Philadelphia, Pa.), 10(4), 226-234. https://doi.org/10.1158/1940-6207.CAPR-16-0249
Rajagopala, Seesandra V, et al. "The Human Microbiome and Cancer." Cancer prevention research (Philadelphia, Pa.) vol. 10,4 (2017): 226-234. doi: https://doi.org/10.1158/1940-6207.CAPR-16-0249
Rajagopala SV, Vashee S, Oldfield LM, Suzuki Y, Venter JC, Telenti A, Nelson KE. The Human Microbiome and Cancer. Cancer Prev Res (Phila). 2017 Apr;10(4):226-234. doi: 10.1158/1940-6207.CAPR-16-0249. Epub 2017 Jan 17. PMID: 28096237.
Copy Download .nbib Format: NLM
Expression of Concern: A BET Bromodomain Inhibitor Suppresses Adiposity-Associated Malignant Transformation.

Cancer prevention research (Philadelphia, Pa.)

[No authors listed]
PMID: 30696633
Cancer Prev Res (Phila). 2019 Jan 29;199-200. doi: 10.1158/1940-6207.CAPR-19-0048. Epub 2019 Jan 29.

No abstract available.

Cite
Expression of Concern: A BET Bromodomain Inhibitor Suppresses Adiposity-Associated Malignant Transformation. Cancer Prev Res (Phila). 2019;199-200doi: 10.1158/1940-6207.CAPR-19-0048.
(2019). Expression of Concern: A BET Bromodomain Inhibitor Suppresses Adiposity-Associated Malignant Transformation. Cancer prevention research (Philadelphia, Pa.), 199-200. https://doi.org/10.1158/1940-6207.CAPR-19-0048
"Expression of Concern: A BET Bromodomain Inhibitor Suppresses Adiposity-Associated Malignant Transformation." Cancer prevention research (Philadelphia, Pa.) vol. (2019): 199-200. doi: https://doi.org/10.1158/1940-6207.CAPR-19-0048
Expression of Concern: A BET Bromodomain Inhibitor Suppresses Adiposity-Associated Malignant Transformation. Cancer Prev Res (Phila). 2019 Jan 29;199-200. doi: 10.1158/1940-6207.CAPR-19-0048. Epub 2019 Jan 29. PMID: 30696633.
Copy Download .nbib Format: NLM
Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis.

Cancer prevention research (Philadelphia, Pa.)

Sanchez JI, Jiao J, Kwan SY, Veillon L, Warmoes MO, Tan L, Odewole M, Rich NE, Wei P, Lorenzi PL, Singal AG, Beretta L.
PMID: 34253566
Cancer Prev Res (Phila). 2021 Oct;14(10):955-962. doi: 10.1158/1940-6207.CAPR-20-0612. Epub 2021 Jul 12.

Novel biomarkers for HCC surveillance in cirrhotic patients are urgently needed. Exosomes and their lipid content in particular represent potentially valuable noninvasive diagnostic biomarkers. We isolated exosomes from plasma of 72 cirrhotic patients, including 31 with HCC. Exosomes and...

Cite
Sanchez JI, Jiao J, Kwan SY, et al. Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila). 2021;14(10):955-962doi: 10.1158/1940-6207.CAPR-20-0612.
Sanchez, J. I., Jiao, J., Kwan, S. Y., Veillon, L., Warmoes, M. O., Tan, L., Odewole, M., Rich, N. E., Wei, P., Lorenzi, P. L., Singal, A. G., & Beretta, L. (2021). Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer prevention research (Philadelphia, Pa.), 14(10), 955-962. https://doi.org/10.1158/1940-6207.CAPR-20-0612
Sanchez, Jessica I, et al. "Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis." Cancer prevention research (Philadelphia, Pa.) vol. 14,10 (2021): 955-962. doi: https://doi.org/10.1158/1940-6207.CAPR-20-0612
Sanchez JI, Jiao J, Kwan SY, Veillon L, Warmoes MO, Tan L, Odewole M, Rich NE, Wei P, Lorenzi PL, Singal AG, Beretta L. Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila). 2021 Oct;14(10):955-962. doi: 10.1158/1940-6207.CAPR-20-0612. Epub 2021 Jul 12. PMID: 34253566; PMCID: PMC8546639.
Copy Download .nbib Format: NLM
Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.

Cancer prevention research (Philadelphia, Pa.)

Bowen CM, Walter L, Borras E, Wu W, Ozcan Z, Chang K, Bommi PV, Taggart MW, Thirumurthi S, Lynch PM, Reyes-Uribe L, Scheet PA, Sinha KM, Vilar E.
PMID: 34266857
Cancer Prev Res (Phila). 2021 Sep;14(9):851-862. doi: 10.1158/1940-6207.CAPR-20-0496. Epub 2021 Jul 15.

Familial adenomatous polyposis (FAP) is a hereditary colorectal cancer syndrome, which results in the development of hundreds of adenomatous polyps carpeting the gastrointestinal tract. NSAIDs have reduced polyp burden in patients with FAP and synthetic rexinoids have demonstrated the...

Cite
Bowen CM, Walter L, Borras E, et al. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis. Cancer Prev Res (Phila). 2021;14(9):851-862doi: 10.1158/1940-6207.CAPR-20-0496.
Bowen, C. M., Walter, L., Borras, E., Wu, W., Ozcan, Z., Chang, K., Bommi, P. V., Taggart, M. W., Thirumurthi, S., Lynch, P. M., Reyes-Uribe, L., Scheet, P. A., Sinha, K. M., & Vilar, E. (2021). Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis. Cancer prevention research (Philadelphia, Pa.), 14(9), 851-862. https://doi.org/10.1158/1940-6207.CAPR-20-0496
Bowen, Charles M, et al. "Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis." Cancer prevention research (Philadelphia, Pa.) vol. 14,9 (2021): 851-862. doi: https://doi.org/10.1158/1940-6207.CAPR-20-0496
Bowen CM, Walter L, Borras E, Wu W, Ozcan Z, Chang K, Bommi PV, Taggart MW, Thirumurthi S, Lynch PM, Reyes-Uribe L, Scheet PA, Sinha KM, Vilar E. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis. Cancer Prev Res (Phila). 2021 Sep;14(9):851-862. doi: 10.1158/1940-6207.CAPR-20-0496. Epub 2021 Jul 15. PMID: 34266857; PMCID: PMC8416926.
Copy Download .nbib Format: NLM
Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States.

Cancer prevention research (Philadelphia, Pa.)

Karia PS, Joshu CE, Visvanathan K.
PMID: 34413116
Cancer Prev Res (Phila). 2021 Dec;14(12):1101-1110. doi: 10.1158/1940-6207.CAPR-21-0121. Epub 2021 Aug 19.

Evidence suggesting that high-grade serous ovarian cancers originate in the fallopian tubes has led to the emergence of opportunistic salpingectomy (OS) as an approach to reduce ovarian-cancer risk. In the U.S., some national societies now recommend OS in place...

Cite
Karia PS, Joshu CE, Visvanathan K. Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States. Cancer Prev Res (Phila). 2021;14(12):1101-1110doi: 10.1158/1940-6207.CAPR-21-0121.
Karia, P. S., Joshu, C. E., & Visvanathan, K. (2021). Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States. Cancer prevention research (Philadelphia, Pa.), 14(12), 1101-1110. https://doi.org/10.1158/1940-6207.CAPR-21-0121
Karia, Pritesh S, et al. "Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States." Cancer prevention research (Philadelphia, Pa.) vol. 14,12 (2021): 1101-1110. doi: https://doi.org/10.1158/1940-6207.CAPR-21-0121
Karia PS, Joshu CE, Visvanathan K. Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States. Cancer Prev Res (Phila). 2021 Dec;14(12):1101-1110. doi: 10.1158/1940-6207.CAPR-21-0121. Epub 2021 Aug 19. PMID: 34413116; PMCID: PMC8756422.
Copy Download .nbib Format: NLM
Dopamine Prevents Ultraviolet B-induced Development and Progression of Premalignant Cutaneous Lesions through its D.

Cancer prevention research (Philadelphia, Pa.)

Lu K, Bhat M, Peters S, Mitra R, Mo X, Oberyszyn TM, Dasgupta PS, Basu S.
PMID: 33846213
Cancer Prev Res (Phila). 2021 Jul;14(7):687-696. doi: 10.1158/1940-6207.CAPR-21-0052. Epub 2021 Apr 12.

Although the role of dopamine (DA) in malignant tumors has been reported, its function in premalignant lesions is unknown. Herein we report that the stimulation of DA D

Cite
Lu K, Bhat M, Peters S, et al. Dopamine Prevents Ultraviolet B-induced Development and Progression of Premalignant Cutaneous Lesions through its D. Cancer Prev Res (Phila). 2021;14(7):687-696doi: 10.1158/1940-6207.CAPR-21-0052.
Lu, K., Bhat, M., Peters, S., Mitra, R., Mo, X., Oberyszyn, T. M., Dasgupta, P. S., & Basu, S. (2021). Dopamine Prevents Ultraviolet B-induced Development and Progression of Premalignant Cutaneous Lesions through its D. Cancer prevention research (Philadelphia, Pa.), 14(7), 687-696. https://doi.org/10.1158/1940-6207.CAPR-21-0052
Lu, Kai, et al. "Dopamine Prevents Ultraviolet B-induced Development and Progression of Premalignant Cutaneous Lesions through its D." Cancer prevention research (Philadelphia, Pa.) vol. 14,7 (2021): 687-696. doi: https://doi.org/10.1158/1940-6207.CAPR-21-0052
Lu K, Bhat M, Peters S, Mitra R, Mo X, Oberyszyn TM, Dasgupta PS, Basu S. Dopamine Prevents Ultraviolet B-induced Development and Progression of Premalignant Cutaneous Lesions through its D. Cancer Prev Res (Phila). 2021 Jul;14(7):687-696. doi: 10.1158/1940-6207.CAPR-21-0052. Epub 2021 Apr 12. PMID: 33846213; PMCID: PMC8295184.
Copy Download .nbib Format: NLM
Statin Exposure and Pancreatic Cancer Incidence: A Japanese Regional Population-Based Cohort Study, the Shizuoka Study.

Cancer prevention research (Philadelphia, Pa.)

Saito K, Sato Y, Nakatani E, Kaneda H, Yamamoto S, Miyachi Y, Itoh H.
PMID: 34244151
Cancer Prev Res (Phila). 2021 Sep;14(9):863-872. doi: 10.1158/1940-6207.CAPR-21-0123. Epub 2021 Jul 09.

Preclinical studies suggest that statins contribute to the prevention of pancreatic cancer; however, the results of epidemiologic studies are inconsistent. Furthermore, sufficient data are unavailable for the general population of Asia. Here, we conducted an observational study using a...

Cite
Saito K, Sato Y, Nakatani E, et al. Statin Exposure and Pancreatic Cancer Incidence: A Japanese Regional Population-Based Cohort Study, the Shizuoka Study. Cancer Prev Res (Phila). 2021;14(9):863-872doi: 10.1158/1940-6207.CAPR-21-0123.
Saito, K., Sato, Y., Nakatani, E., Kaneda, H., Yamamoto, S., Miyachi, Y., & Itoh, H. (2021). Statin Exposure and Pancreatic Cancer Incidence: A Japanese Regional Population-Based Cohort Study, the Shizuoka Study. Cancer prevention research (Philadelphia, Pa.), 14(9), 863-872. https://doi.org/10.1158/1940-6207.CAPR-21-0123
Saito, Kohei, et al. "Statin Exposure and Pancreatic Cancer Incidence: A Japanese Regional Population-Based Cohort Study, the Shizuoka Study." Cancer prevention research (Philadelphia, Pa.) vol. 14,9 (2021): 863-872. doi: https://doi.org/10.1158/1940-6207.CAPR-21-0123
Saito K, Sato Y, Nakatani E, Kaneda H, Yamamoto S, Miyachi Y, Itoh H. Statin Exposure and Pancreatic Cancer Incidence: A Japanese Regional Population-Based Cohort Study, the Shizuoka Study. Cancer Prev Res (Phila). 2021 Sep;14(9):863-872. doi: 10.1158/1940-6207.CAPR-21-0123. Epub 2021 Jul 09. PMID: 34244151.
Copy Download .nbib Format: NLM
Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk.

Cancer prevention research (Philadelphia, Pa.)

Sasamoto N, Babic A, Vitonis AF, Titus L, Cramer DW, Trabert B, Tworoger SS, Terry KL.
PMID: 34244153
Cancer Prev Res (Phila). 2021 Aug;14(8):795-802. doi: 10.1158/1940-6207.CAPR-21-0090. Epub 2021 Jul 09.

Menstrual pain has been associated with increased ovarian cancer risk, presumably through increased inflammation, which is known to play a critical role in ovarian carcinogenesis. Analgesic medications are frequently used to treat menstrual pain, some of which lower ovarian...

Cite
Sasamoto N, Babic A, Vitonis AF, et al. Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk. Cancer Prev Res (Phila). 2021;14(8):795-802doi: 10.1158/1940-6207.CAPR-21-0090.
Sasamoto, N., Babic, A., Vitonis, A. F., Titus, L., Cramer, D. W., Trabert, B., Tworoger, S. S., & Terry, K. L. (2021). Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk. Cancer prevention research (Philadelphia, Pa.), 14(8), 795-802. https://doi.org/10.1158/1940-6207.CAPR-21-0090
Sasamoto, Naoko, et al. "Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk." Cancer prevention research (Philadelphia, Pa.) vol. 14,8 (2021): 795-802. doi: https://doi.org/10.1158/1940-6207.CAPR-21-0090
Sasamoto N, Babic A, Vitonis AF, Titus L, Cramer DW, Trabert B, Tworoger SS, Terry KL. Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk. Cancer Prev Res (Phila). 2021 Aug;14(8):795-802. doi: 10.1158/1940-6207.CAPR-21-0090. Epub 2021 Jul 09. PMID: 34244153; PMCID: PMC8344407.
Copy Download .nbib Format: NLM
Vitamin D as a Potential Preventive Agent For Young Women's Breast Cancer.

Cancer prevention research (Philadelphia, Pa.)

Bernhardt SM, Borges VF, Schedin P.
PMID: 34244152
Cancer Prev Res (Phila). 2021 Sep;14(9):825-838. doi: 10.1158/1940-6207.CAPR-21-0114. Epub 2021 Jul 09.

Clinical studies backed by research in animal models suggest that vitamin D may protect against the development of breast cancer, implicating vitamin D as a promising candidate for breast cancer prevention. However, despite clear preclinical evidence showing protective roles...

Cite
Bernhardt SM, Borges VF, Schedin P. Vitamin D as a Potential Preventive Agent For Young Women's Breast Cancer. Cancer Prev Res (Phila). 2021;14(9):825-838doi: 10.1158/1940-6207.CAPR-21-0114.
Bernhardt, S. M., Borges, V. F., & Schedin, P. (2021). Vitamin D as a Potential Preventive Agent For Young Women's Breast Cancer. Cancer prevention research (Philadelphia, Pa.), 14(9), 825-838. https://doi.org/10.1158/1940-6207.CAPR-21-0114
Bernhardt, Sarah M, et al. "Vitamin D as a Potential Preventive Agent For Young Women's Breast Cancer." Cancer prevention research (Philadelphia, Pa.) vol. 14,9 (2021): 825-838. doi: https://doi.org/10.1158/1940-6207.CAPR-21-0114
Bernhardt SM, Borges VF, Schedin P. Vitamin D as a Potential Preventive Agent For Young Women's Breast Cancer. Cancer Prev Res (Phila). 2021 Sep;14(9):825-838. doi: 10.1158/1940-6207.CAPR-21-0114. Epub 2021 Jul 09. PMID: 34244152.
Copy Download .nbib Format: NLM
Economic Evaluation of Web- versus Telephone-based Interventions to Simultaneously Increase Colorectal and Breast Cancer Screening Among Women.

Cancer prevention research (Philadelphia, Pa.)

Huang D, Lairson DR, Chung TH, Monahan PO, Rawl SM, Champion VL.
PMID: 34244154
Cancer Prev Res (Phila). 2021 Sep;14(9):905-916. doi: 10.1158/1940-6207.CAPR-21-0009. Epub 2021 Jul 09.

Screening for colorectal and breast cancer is considered cost effective, but limited evidence exists on cost-effectiveness of screening promotion interventions that simultaneously target both cancers. Increasing Colorectal and Breast Cancer Screening (Project COBRA), a randomized controlled trial conducted in...

Cite
Huang D, Lairson DR, Chung TH, et al. Economic Evaluation of Web- versus Telephone-based Interventions to Simultaneously Increase Colorectal and Breast Cancer Screening Among Women. Cancer Prev Res (Phila). 2021;14(9):905-916doi: 10.1158/1940-6207.CAPR-21-0009.
Huang, D., Lairson, D. R., Chung, T. H., Monahan, P. O., Rawl, S. M., & Champion, V. L. (2021). Economic Evaluation of Web- versus Telephone-based Interventions to Simultaneously Increase Colorectal and Breast Cancer Screening Among Women. Cancer prevention research (Philadelphia, Pa.), 14(9), 905-916. https://doi.org/10.1158/1940-6207.CAPR-21-0009
Huang, Danmeng, et al. "Economic Evaluation of Web- versus Telephone-based Interventions to Simultaneously Increase Colorectal and Breast Cancer Screening Among Women." Cancer prevention research (Philadelphia, Pa.) vol. 14,9 (2021): 905-916. doi: https://doi.org/10.1158/1940-6207.CAPR-21-0009
Huang D, Lairson DR, Chung TH, Monahan PO, Rawl SM, Champion VL. Economic Evaluation of Web- versus Telephone-based Interventions to Simultaneously Increase Colorectal and Breast Cancer Screening Among Women. Cancer Prev Res (Phila). 2021 Sep;14(9):905-916. doi: 10.1158/1940-6207.CAPR-21-0009. Epub 2021 Jul 09. PMID: 34244154; PMCID: PMC8416925.
Copy Download .nbib Format: NLM
Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model.

Cancer prevention research (Philadelphia, Pa.)

Shi Y, Xie TX, Leach DG, Wang B, Young S, Osman AA, Sikora AG, Ren X, Hartgerink JD, Myers JN, Rangel R.
PMID: 34021022
Cancer Prev Res (Phila). 2021 Aug;14(8):767-778. doi: 10.1158/1940-6207.CAPR-20-0607. Epub 2021 May 21.

Although the principle of systemic treatment to prevent the progression of oral premalignant lesions (OPL) has been demonstrated, there remains a lack of consensus about an optimal approach that balances clinical efficacy with toxicity concerns. Recent advances in cancer...

Cite
Shi Y, Xie TX, Leach DG, et al. Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model. Cancer Prev Res (Phila). 2021;14(8):767-778doi: 10.1158/1940-6207.CAPR-20-0607.
Shi, Y., Xie, T. X., Leach, D. G., Wang, B., Young, S., Osman, A. A., Sikora, A. G., Ren, X., Hartgerink, J. D., Myers, J. N., & Rangel, R. (2021). Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model. Cancer prevention research (Philadelphia, Pa.), 14(8), 767-778. https://doi.org/10.1158/1940-6207.CAPR-20-0607
Shi, Yewen, et al. "Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model." Cancer prevention research (Philadelphia, Pa.) vol. 14,8 (2021): 767-778. doi: https://doi.org/10.1158/1940-6207.CAPR-20-0607
Shi Y, Xie TX, Leach DG, Wang B, Young S, Osman AA, Sikora AG, Ren X, Hartgerink JD, Myers JN, Rangel R. Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model. Cancer Prev Res (Phila). 2021 Aug;14(8):767-778. doi: 10.1158/1940-6207.CAPR-20-0607. Epub 2021 May 21. PMID: 34021022; PMCID: PMC8338806.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 243 entries